Item Type | Name |
Concept
|
Arthritis
|
Concept
|
Arthritis, Rheumatoid
|
Academic Article
|
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.
|
Academic Article
|
Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.
|
Academic Article
|
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.
|
Academic Article
|
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.
|
Academic Article
|
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
|
Academic Article
|
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.
|
Academic Article
|
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.
|
Academic Article
|
Rituximab: wanted dead or alive...
|
Academic Article
|
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
|
Academic Article
|
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
|
Academic Article
|
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
|
Academic Article
|
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
|
Academic Article
|
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
|
Academic Article
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
|
Academic Article
|
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
|
Academic Article
|
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
|
Academic Article
|
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.
|
Academic Article
|
Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares.
|
Academic Article
|
Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
|
Academic Article
|
Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
|
Academic Article
|
Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
|
Academic Article
|
Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
|
Academic Article
|
Editorial: Lupus, the Chameleon: Many Disguises Difficult to Capture.
|
Academic Article
|
Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
|
Academic Article
|
Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.
|
Academic Article
|
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
|
Academic Article
|
Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
|
Academic Article
|
Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria.
|
Academic Article
|
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.
|
Academic Article
|
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
|
Academic Article
|
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
|
Academic Article
|
The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis.
|
Academic Article
|
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.
|
Academic Article
|
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.
|
Academic Article
|
Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls.
|
Academic Article
|
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
|
Academic Article
|
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
|
Academic Article
|
TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.
|
Academic Article
|
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
|
Academic Article
|
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.
|
Academic Article
|
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.
|
Academic Article
|
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
|
Academic Article
|
Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
|
Academic Article
|
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
|
Academic Article
|
A 2014 update on the management of patients with systemic lupus erythematosus.
|
Academic Article
|
Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.
|
Academic Article
|
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.
|
Academic Article
|
Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians.
|
Academic Article
|
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
|
Academic Article
|
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
|
Academic Article
|
Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.
|
Academic Article
|
Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies.
|
Academic Article
|
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
|
Academic Article
|
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.
|
Academic Article
|
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.
|
Academic Article
|
A polymorphism within IL21R confers risk for systemic lupus erythematosus.
|
Academic Article
|
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
|
Academic Article
|
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
|
Academic Article
|
Disease-specific patient reported outcome tools for systemic lupus erythematosus.
|
Academic Article
|
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
|
Academic Article
|
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
|
Academic Article
|
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
|
Academic Article
|
A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.
|
Academic Article
|
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
|
Academic Article
|
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Low frequency of flares during pregnancy and post-partum in stable lupus patients.
|
Academic Article
|
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
|
Academic Article
|
SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes.
|
Academic Article
|
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
|
Academic Article
|
Novel evidence-based systemic lupus erythematosus responder index.
|
Academic Article
|
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21.
|
Academic Article
|
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.
|
Academic Article
|
Evaluation of TRAF6 in a large multiancestral lupus cohort.
|
Academic Article
|
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
|
Academic Article
|
Reply: To PMID 22556106.
|
Academic Article
|
Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).
|
Academic Article
|
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.
|
Academic Article
|
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
|
Academic Article
|
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A.
|
Academic Article
|
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
|
Academic Article
|
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design.
|
Academic Article
|
Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
|
Academic Article
|
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
|
Academic Article
|
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus.
|
Academic Article
|
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
|
Academic Article
|
Selection of a gene for apolipoprotein A1 using autoantibodies from a patient with systemic lupus erythematosus.
|
Academic Article
|
What Did Not Work: The Drug or the Trial?
|
Academic Article
|
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort.
|
Academic Article
|
Reply.
|
Academic Article
|
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
|